Anti-Counterfeiting Strategies - Combating Fake Pharmaceuticals

Scope

Overview of the prevalence and drivers of counterfeit medicines, examining the economic and health cost of fake medicines

Analysis of how counterfeit medicines enter the market, and strategies taken to tighten up supply chain security

Assessment of key anti-counterfeiting technologies employed by pharmaceutical manufacturers, supported by case study analysis

Examination
of governmental and NGO based initiatives to improve regulation,
legislation and enforcement of anti-counterfeiting protocols

Report
Highlights

Incidents
of counterfeit medicines are on the increase. However, reported figures
only represent the tip of the iceberg, particularly in developing
countries due to the insufficient anti-counterfeiting resources
available

Parallel importation and online
pharmacies are increasingly becoming the route of choice for
counterfeiters to distribute fake medicines to patients on a global
scale. Find out why, and what is being done to address these matters

Currently,
2D-barcodes and radio frequency identification tagging (RFID) are the
two most prominent track & trace technologies. However, with the
FDA having no preference, which technologies will pharmaceutical
companies opt for?